Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Princess Máxima Center for Pediatric Oncology

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Princess Máxima Center for Pediatric Oncology is the largest pediatric cancer center in Europe. Opened in May 2018, this specialized research hospital completely centralized all highly complex childhood cancer care, research, and training in the Netherlands under one roof. Driven by a mission to achieve a 100% cure rate while maintaining an optimal quality of life, the center operates across four distinct departments: Hemato-Oncology, Solid Tumors, Neuro-Oncology, and Quality-of-Life.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Children's hospital

Business Subcategory

Source: Human-provided. Children's hospital
Source: Human-provided. Research institute
Source: Trial-derived.
28Total Trials
Source: Trial-derived.
5Recruiting Trials
Source: Trial-derived.
13Active Trials
Source: Trial-derived.
11Completed Trials
Source: Trial-derived.
53Unique Conditions
Source: Trial-derived.
73Unique Sponsors

Conditions

Source: Trial-derived. Acute Lymphoblastic Leukemia (ALL) (2)Source: Trial-derived. Adrenoleukodystrophy (ALD) (2)Source: Trial-derived. Cerebral Adrenoleukodystrophy (CALD) (2)Source: Trial-derived. Neuroblastoma (2)Source: Trial-derived. X-Linked Adrenoleukodystrophy (X-ALD) (2)Source: Trial-derived. Acute Myeloid Leukemia (1)Source: Trial-derived. Acute Myeloid Leukemia (AML) (1)Source: Trial-derived. ALK-positive Histiocytosis (1)

Sponsors

Source: Trial-derived. European Organisation for Research and Treatment of Cancer - EORTC (3)Source: Trial-derived. Gustave Roussy, Cancer Campus, Grand Paris (3)Source: Trial-derived. Australian & New Zealand Children's Haematology/Oncology Group (2)Source: Trial-derived. Centre Hospitalier Universitaire de Nice (2)Source: Trial-derived. Charite University, Berlin, Germany (2)Source: Trial-derived. Children's Oncology Group (2)Source: Trial-derived. Deutsche Krebshilfe e.V., Bonn (Germany) (2)Source: Trial-derived. Fight Kids Cancer (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. MRI
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Echocardiography
Source: AI-inferred. MR spectroscopy

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Circulating tumour DNA testing
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. Flow Cytometry
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Apheresis
Source: AI-inferred. Lumbar puncture
Source: AI-inferred. Neonatal and paediatric anaesthesia
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Allogeneic haematopoietic stem cell transplantation
Source: AI-inferred. Cytogenetic testing
Source: AI-inferred. Donor chimerism testing
Source: AI-inferred. Intracerebroventricular (Ommaya reservoir) drug administration
Source: AI-inferred. Intrathecal chemotherapy administration
Source: AI-inferred. Intratumoral CNS infusion via neuro ventricular cannula
Source: AI-inferred. Measurable residual disease testing
Source: AI-inferred. Microbiome analysis